BioCentury
ARTICLE | Clinical News

Immunex regulatory update

March 18, 1996 8:00 AM UTC

IMNX’s VP-16 (etoposide injection) generic chemotherapeutic received FDA approval to treat refractory testicular tumors and small cell lung cancer. ...